Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.07 USD | -2.75% | -2.79% | -18.46% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Business Summary
Number of employees: 278
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapies
100.0
%
| 77 | 100.0 % | 186 | 100.0 % | +141.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
82.0
%
| 77 | 100.0 % | 147 | 82.0 % | +90.36% |
Rest of World
18.0
%
| - | - | 32 | 18.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Eric Bjerkholt
DFI | Director of Finance/CFO | 64 | 23-09-10 |
Pamela Vig
CTO | Chief Tech/Sci/R&D Officer | 53 | 18-11-30 |
Joanne Quan
CTO | Chief Tech/Sci/R&D Officer | 60 | Jan. 15 |
Paul K. Ross
CMP | Compliance Officer | - | 20-03-31 |
Andrew McKibben
IRC | Investor Relations Contact | - | - |
Erin Campany
HRO | Human Resources Officer | 57 | 21-12-31 |
Corporate Officer/Principal | 54 | 18-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Laurent Fischer
BRD | Director/Board Member | 60 | 19-05-31 |
Laura Brege
BRD | Director/Board Member | 66 | 19-07-16 |
Director/Board Member | 48 | 22-06-01 | |
Founder | 45 | 18-05-06 | |
Lon Cardon
BRD | Director/Board Member | 58 | 22-12-18 |
William Fairey
BRD | Director/Board Member | 60 | 21-08-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,133,021 | 45,959,439 ( 97.51 %) | 0 | 97.51 % |
Company contact information
Mirum Pharmaceuticals, Inc.
950 Tower Lane Suite 1050
94404, Foster City
+650 667 4085
http://www.mirumpharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.46% | 1.13B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |
- Stock Market
- Equities
- MIRM Stock
- Company Mirum Pharmaceuticals, Inc.